Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

NCT00554827 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Cutaneous T-cell Lymphoma

Interventions

DIETARY_SUPPLEMENT: Vitamin B12
DIETARY_SUPPLEMENT: Folic Acid
DRUG: Pralatrexate

Sponsor

Acrotech Biopharma Inc.